Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN110105242A reveals a continuous OTBN synthesis method enhancing yield and purity. Discover cost-effective manufacturing and reliable supply chain solutions.
Novel nitrone-based route for branched polyhydroxypyrrolidine derivatives offers high stereoselectivity and scalable manufacturing for imino sugar intermediates.
Novel esterification and deprotection technology for candesartan cilexetil intermediates. High yield, mild conditions, suitable for large-scale pharmaceutical manufacturing.
Patent CN101351459A reveals a novel acetic acid-catalyzed route for 4(3H)-quinazolinone derivatives, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN101848905A details a novel enantioselective route for (S)-pregabalin using D-mannitol, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel low-valent titanium method for HIV protease inhibitor intermediates offering cost-effective scale-up and high purity for global pharma supply chains.
Discover the novel three-step synthesis of alpha,alpha-fluorochloroarylmethyl phosphonates via Pudovik addition and electrophilic fluorination for PTPs inhibitor development.
Novel palladium-free synthesis route for high-purity pharmaceutical intermediates. Reduces cost and simplifies supply chain for global API manufacturing partners.
Patent CN1033521A reveals a safer route to Famotidine intermediates using bicyclic amidine salts, eliminating toxic hydrogen sulfide and improving supply chain reliability for pharmaceutical manufacturers.
Novel metal-catalyzed process for 1-beta-methyl carbapenem intermediates. High yield, mild conditions, scalable production for global supply chains.
Patent CN1066728C reveals a robust 3-step route for epoxide intermediates, offering significant cost reduction in pharmaceutical manufacturing and improved supply chain reliability.
Patent CN1486316A details a one-pot synthesis for carbapenems. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN114920670B reveals a novel two-step synthesis for 5-chloro-2-aminobenzenesulfonamide, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Advanced synthesis of masitinib intermediates via patent CN115850258A. Offers cost reduction in API manufacturing and reliable supply chain solutions for global pharma.
Patent CN1084166A reveals novel benzothiazolyl methoxy phenyl-acetic acid synthesis. Enables cost reduction in API manufacturing for leukotriene inhibitors.
Patent CN1150169C details efficient cyclization of amidine intermediates. High purity API precursors for oncology drugs like Temozolomide.
Patent CN106146433A reveals a streamlined synthesis for Sofosbuvir intermediates offering high purity and scalable production for global pharmaceutical supply chains.
Patent CN1227250C reveals a safer, scalable route for CDK inhibitor intermediates, eliminating hazardous diazo compounds and chromatography for cost-effective manufacturing.
Advanced patent CN1580058A method for high-purity 3-chloromethyl-3-cephem derivatives. Direct crystallization improves stability and reduces manufacturing costs for cephalosporin intermediates.
Patent CN1525964A reveals a novel high-purity Biperiden synthesis route. Discover cost-effective manufacturing solutions for Parkinson's disease API intermediates with superior stereocontrol.